)0:$20NN72IH+23&FBB#<E3?7{=L
SYSTEM PROCESSING...
)0:$20NN72IH+23&FBB#<E3?7{=L
SYSTEM PROCESSING...
Posted: 2025-04-24 04:46:16 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-24 04:47:26 UTC
Verified By
Rollup News
The LEADR Trial evaluated the OmniaSecure defibrillation lead, demonstrating its safety, efficacy, and robust sensing and detection performance. The lead features a small-diameter design for reliability and targeted placement.
Safety and efficacy
Robust sensing and detection performance
Small-diameter design for targeted placement
Low adverse event rate related to oversensing
Ensuring accurate sensing and detection
Minimizing adverse events related to oversensing